GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oculis Holding AG (NAS:OCS) » Definitions » Other Long Term Assets

Oculis Holding AG (Oculis Holding AG) Other Long Term Assets : $0.10 Mil (As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Oculis Holding AG Other Long Term Assets?

Oculis Holding AG's other long-term assets for the quarter that ended in Mar. 2024 was $0.10 Mil.

Oculis Holding AG's quarterly other long-term assets declined from Sep. 2023 ($0.14 Mil) to Dec. 2023 ($0.10 Mil) but then stayed the same from Dec. 2023 ($0.10 Mil) to Mar. 2024 ($0.10 Mil).

Oculis Holding AG's annual other long-term assets increased from Dec. 2021 ($-0.00 Mil) to Dec. 2022 ($0.03 Mil) and increased from Dec. 2022 ($0.03 Mil) to Dec. 2023 ($0.10 Mil).


Oculis Holding AG Other Long Term Assets Historical Data

The historical data trend for Oculis Holding AG's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oculis Holding AG Other Long Term Assets Chart

Oculis Holding AG Annual Data
Trend Dec20 Dec21 Dec22 Dec23
Other Long Term Assets
0.01 - 0.03 0.10

Oculis Holding AG Quarterly Data
Dec20 Jun21 Sep21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.13 0.14 0.10 0.10

Oculis Holding AG Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Oculis Holding AG (Oculis Holding AG) Business Description

Traded in Other Exchanges
Address
Bahnhofstrasse 7, Zug, CHE, 6300
Oculis Holding AG is a global biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis.